| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Weiser Michael serves as a Director at TCRT and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 2 buys and 0 sells. Those positions are worth an estimated $1.6M at current prices.
The biggest single holding is TCRT (~$929K) as Director.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 31, 2022 | IOVA Iovance Biotherapeutics, Inc. | Director | Buy | 10,000 | $6.80 | $67,978.13 | +9.7% | +58.5% | +29.5% |